AGT and autosomal dominant polycystic kidney disease: Unravelling the mechanisms involving intrarenal RAS activation in ADPKD is beyond the scope of this study since this study aims to investigate the clinical usefulness of urinary AGT/Cr as a biomarker of renal insufficiency.